Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Muthukumar Karuppasamy
Institutions:
Children's of Alabama,
University of Alabama at Birmingham,
UAB Medicine
Observed institutions:
Birla Institute of Technology, Mesra,
National University of Singapore,
Children's of Alabama,
University of Alabama at Birmingham,
UAB Medicine
ORCID:
0000-0003-0034-9950
Observed ORCID:
0000-0003-0034-9950
OpenAlex ID:
A5079133716
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes
2022
·
Manoj Kumar Mahapatra
, Muthukumar Karuppasamy
, et al.
·
Reviews in Endocrine and Metabolic Disorders
·
196
PDF
Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review
2022
·
Manoj K. Mahapatra
, Muthukumar Karuppasamy
, et al.
·
Pharmaceutical Research
·
123
PDF
Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies
2010
·
Muthukumar Karuppasamy
, Manojkumar Mahapatra
, et al.
·
Bioorganic & Medicinal Chemistry
·
57
Fundamental considerations in drug design
2022
·
Manoj Kumar Mahapatra
, Muthukumar Karuppasamy
·
Elsevier eBooks
·
41
PDF
Evaluation of wound healing and antimicrobial potentials of Ixora coccinea root extract
2011
·
Nagaraj Selvaraj
, Baskar Lakshmanan
, et al.
·
Asian Pacific Journal of Tropical Medicine
·
33
PDF
Novel dual-targeting anti-proliferative dihydrotriazine-chalcone derivatives display suppression of cancer cell invasion and inflammation by inhibiting the NF-κB signaling pathway
2018
·
Fei-Fei Gan
, Ruirui Zhang
, et al.
·
Food and Chemical Toxicology
·
30
Standardization of zebrafish drug testing parameters for muscle diseases
2024
·
Muthukumar Karuppasamy
, Katherine G. English
, et al.
·
Disease Models & Mechanisms
·
22
PDF
DOCK3 regulates normal skeletal muscle regeneration and glucose metabolism
2023
·
Adrienne Samani
, Muthukumar Karuppasamy
, et al.
·
The FASEB Journal
·
10
PDF
Ribisins and Certain Analogues Exert Neuroprotective Effects through Activation of the Keap1‐Nrf2‐ARE Pathway
2022
·
Shen H. Tan
, Muthukumar Karuppasamy
, et al.
·
ChemMedChem
·
5
Conditional Dmd ablation in muscle and brain causes profound effects on muscle function and neurobehavior
2025
·
Muthukumar Karuppasamy
, Katherine G. English
, et al.
·
Communications Biology
·
3
PDF
X-linked myopathy with excessive autophagy: characterization and therapy testing in a zebrafish model
2025
·
Lily Huang
, Rebecca Simonian
, et al.
·
EMBO Molecular Medicine
·
2
PDF
DOCK7 regulates WNT signaling and NMJ clustering in normal and DMD muscle
2025
·
Katherine G. English
, Shelby N. Rorrer
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
Restoration of brain dystrophin using tricyclo-DNA ASOs restores neurobehavioral deficits in DMD mice
2023
·
Muthukumar Karuppasamy
, Matthew S. Alexander
·
Molecular Therapy — Nucleic Acids
·
1
PDF
Editorial: Diagnosis, animal models and therapeutic interventions for neuromuscular diseases
2024
·
Muthukumar Karuppasamy
, Martine Tetreault
, et al.
·
Frontiers in Genetics
PDF
Biological Characterization of the Anti-Tumor Properties of Novel Dual-Target Inhibitors of Dihydrofolate Reductase and Thioredoxin Reductase
2016
·
Eng-Hui Chew
, Hui-Li Ng
, et al.
·
Free Radical Biology and Medicine
Exploration of the Antioxidant and Nrf2 Inducing Properties of a Group of Small Molecule Compounds That Mimic Peptide Inhibitors of Keap1-Nrf2 Interaction
2015
·
Eng-Hui Chew
, Muthukumar Karuppasamy
, et al.
·
Free Radical Biology and Medicine
How can India influence drug discovery and development
2013
·
Rao Ks
, Pratima Bichandarkoil Jayaram
, et al.
Show more works
View as search
Works count:
18
Citation count:
524
H-index:
8
I10-index:
8
Year
Topic
Type